[Federal Register Volume 86, Number 186 (Wednesday, September 29, 2021)]
[Notices]
[Pages 53985-53986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21101]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-902]


Bulk Manufacturer of Controlled Substances Application: Cambridge 
Isotope Laboratories, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cambridge Isotope Laboratories, Inc., has applied to be 
registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to SUPPLEMENTAL INFORMATION listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before November 29, 
2021. Such persons may also file a written request for a hearing on the 
application on or before November 29, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on July 29, 2021, Cambridge Isotope Laboratories, Inc., 
50 Frontage Drive, Andover, Massachusetts 01810-5413, applied to be 
registered as a bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols..................     7370  I
------------------------------------------------------------------------

    The company plans to synthetically bulk manufacture the controlled

[[Page 53986]]

substance Tetrahydrocannabinols to produce analytical standards for 
distribution to its customers. No other activity for this drug code is 
authorized for this registration.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-21101 Filed 9-28-21; 8:45 am]
BILLING CODE;P